BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37520254)

  • 1. Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis.
    Chen Z; Ma Y; Dong Y; Chen C; Wang H; Wang T; Yu J; Hong X; Chen M; He X; Ju W
    PeerJ; 2023; 11():e15620. PubMed ID: 37520254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver disease.
    Yu J; Shi X; Yu H; Wu J; Ma J; Dong S; Lu S; Zheng S; Li L; Xu X; Cao H
    J Med Virol; 2022 Jul; 94(7):3338-3348. PubMed ID: 35257389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of hepatitis B virus surface antigen positive grafts in liver transplantation: A matched study based on a national registry cohort.
    Yu S; Cen C; Zhang X; Cheng L; Xia W; Jia J; Ye Y; Yu J; Zhang M; Shen Y; Zheng S
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1052-1059. PubMed ID: 35249229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
    Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
    J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.
    Chancharoenthana W; Townamchai N; Pongpirul K; Kittiskulnam P; Leelahavanichkul A; Avihingsanon Y; Suankratay C; Wattanatorn S; Kittikowit W; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Transplant; 2014 Dec; 14(12):2814-20. PubMed ID: 25395260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
    Wong TC; Fung JY; Cui TY; Lam AH; Dai JW; Chan AC; Cheung TT; Chok KS; Ng KK; Lo CM
    J Hepatol; 2019 Jun; 70(6):1114-1122. PubMed ID: 30871981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients.
    Krishnamoorthi R; Manickam P; Cappell MS
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):113-8. PubMed ID: 24780945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
    Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
    BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities.
    Bhatnagar A; Prakash S; Lymberopoulos P; Goff C; Shaikh A; Kim D; Ahmed A; Berg C; Naggie S; Kanwal F; Cholankeril G; Lee TH
    Am J Transplant; 2023 Aug; 23(8):1221-1226. PubMed ID: 37116583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection.
    He Z; Chen J; Wang J; Xu L; Zhou Z; Chen M; Zhang Y; Shi M
    Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):76-82. PubMed ID: 32049678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome and recurrence of hepatitis B virus following liver transplantation from hepatitis B surface antigen-positive donors in a Chinese population.
    Wei L; Chen D; Zhang B; Zhao Y; Liu B; Shi H; Zeng F; Ming C; Jiang J; Du D; Chen Z
    J Viral Hepat; 2018 Dec; 25(12):1576-1581. PubMed ID: 30009520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.
    Ko WJ; Chou NK; Hsu RB; Chen YS; Wang SS; Chu SH; Lai MY
    J Heart Lung Transplant; 2001 Aug; 20(8):865-75. PubMed ID: 11502409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
    Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
    J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.
    Loggi E; Conti F; Cucchetti A; Ercolani G; Pinna AD; Andreone P
    World J Gastroenterol; 2016 Sep; 22(35):8010-6. PubMed ID: 27672295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.
    Lu D; Yang F; Zhuo J; Yang M; Lin Z; Jin P; Cai X; Cen B; Wang J; Wei X; Zheng S; Xu X
    Clin Transl Gastroenterol; 2020 May; 11(5):e00168. PubMed ID: 32358239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney transplantation from hepatitis B surface antigen positive donors into hepatitis B surface antibody positive recipients: a prospective nonrandomized controlled study from a single center.
    Jiang H; Wu J; Zhang X; Wu D; Huang H; He Q; Wang R; Wang Y; Zhang J; Chen J
    Am J Transplant; 2009 Aug; 9(8):1853-8. PubMed ID: 19538486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.